Determinants and Prevalence of Impotence among Diabetic Patients in Northwestern Hospitals of Nefasit, Eretria

Figures & data

Table 1 Sociodemographic variables related to impotence among diabetic patients

	n (%)
Age, years
<30	62 (25.94%)
30–44	72 (30.12%)
45–59	61 (25.52%)
≥60	44 (18.41%)
Ethnicity
Tigray	225 (94.14%)
Others	14 (5.85%)
Marital status
Married	210 (87.86%)
Single	22 (9.20%)
Separated	3 (1.25%)
Widowed	1 (0.41%)
Divorced	3 (1.25%)
Religion
Orthodox	212 (88.70%)
Muslim	24 (10.04%)
Others	3 (1.25%)
Education
Illiterate	58 (24.26%)
Grades 1–8	112 (46.86%)
Grades 9–12	30 (12.55%)
College/university	39 (16.31%)
Occupation
Farmer	122 (51.04%)
Government employee	47 (19.66%)
NGO employee	24 (10.04%)
Merchant	20 (8.36%)
Daily laborer	14 (5.85%)
Other	12 (5.02%)
Monthly income (US$)
<25	104 (43.51%)
25–50	62 (25.94%)
>50	73 (30.54%)

Table 2 Clinical variables among impotent diabetic patients

	Impotence	No impotence	Total
Type of DM
1	105	48	153
2	64	22	86
BMI
Underweight	65	18	83
Normal	90	42	132
Overweight	15	9	24
Obese	0	0	0
BP
Normal	140	22	162
Stage 1	6	18	24
Stage 2	29	24	53
DM duration (years)
<5	89	39	128
5–10	36	20	56
>10	38	17	55
Smoking
Yes	17	4	21
No	152	66	218
Physical exercise
Yes	42	49	91
No	130	18	148
Drink alcohol
Yes	69	22	91
No	84	64	148
FBS (mg/dL)
<126	66	20	86
≥126	98	55	153

Figure 1 Prevalence of impotence among DM patients.

Notes: The of impotence incidence was found to be very high. Approximately a third of participants had normal erectile behavior. In fact, the of erectile dysfunction incidence in type 1 DM patients was significantly lower than in type 2 DM patients.

Table 3 Multivariate logistic regression factors affecting impotence among diabetic patients

	AOR	95% CI	P
Age
<30 years	1.1	—	—
30–48 years	1.14	0.489–2.126	0.96
49–60 years	2.18	0.909–4.86	0.088
>60 years	14.21	3.22–70.10	0.001*
Income (US$)
<25	1.1	—	—
25–50	0.462	0.234–1.011	0.058
>50	0.279	0.133–0.614	0.001*
DM duration
<5 years	1.1	—	—
5–10 years	1.072	0.544–2.012	0.876
>10 years	4.1	0.133–11.614	0.014*
Comorbidity
No	1.1	—	—
Yes	1.542	0.684–3.642	0.34

Note: *P<0.05.